Lumeda Announces Closing of $4.3M Series A Financing with Clinical Studies Due to Commence in 2021
Share Article
Funding to advance product design and clinical testing as company strives to improve outcomes for lung cancer patients ROCKY HILL, Conn. (PRWEB) April 08, 2021
Lumeda Inc., a medical technology company advancing Photodynamic Therapy (PDT) as an intraoperative adjuvant treatment for patients during lung cancer surgery, today announced the closing of its Series A financing. The round was led by Connecticut Innovations, with participation from Cycle Venture Partners and brings the total amount raised to date to $5.3M. Both firms, along with angel investors, participated in the company’s Seed funding round in early 2020. The new capital will be used to further develop Lumeda’s breakthrough PDT system, which leverages artificial intelligence (AI) and proprietary software and hardware to enable controlle